UniSa - IRIS Institutional Research Information System

ERRO, Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.727
EU - Europa 2.501
AS - Asia 2.445
SA - Sud America 458
OC - Oceania 63
AF - Africa 33
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.230
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.643
SG - Singapore 987
IT - Italia 669
CN - Cina 565
RU - Federazione Russa 497
BR - Brasile 420
UA - Ucraina 354
IE - Irlanda 308
TR - Turchia 276
DE - Germania 220
KR - Corea 198
SE - Svezia 173
VN - Vietnam 164
HK - Hong Kong 124
FI - Finlandia 70
GB - Regno Unito 69
CA - Canada 50
IN - India 50
EE - Estonia 36
AU - Australia 35
NL - Olanda 28
NZ - Nuova Zelanda 28
AT - Austria 23
MX - Messico 21
CZ - Repubblica Ceca 13
AR - Argentina 12
BD - Bangladesh 12
IQ - Iraq 12
JP - Giappone 11
ZA - Sudafrica 10
PL - Polonia 9
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
FR - Francia 6
MA - Marocco 6
VE - Venezuela 6
BE - Belgio 5
DZ - Algeria 5
IR - Iran 5
KE - Kenya 5
PY - Paraguay 5
CO - Colombia 4
DO - Repubblica Dominicana 4
EC - Ecuador 4
ID - Indonesia 4
JM - Giamaica 4
LT - Lituania 4
PK - Pakistan 4
CL - Cile 3
EG - Egitto 3
GR - Grecia 3
IL - Israele 3
JO - Giordania 3
NP - Nepal 3
AL - Albania 2
BO - Bolivia 2
CI - Costa d'Avorio 2
ES - Italia 2
EU - Europa 2
KW - Kuwait 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
UY - Uruguay 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
DK - Danimarca 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
LK - Sri Lanka 1
ME - Montenegro 1
MK - Macedonia 1
OM - Oman 1
PH - Filippine 1
QA - Qatar 1
SA - Arabia Saudita 1
TH - Thailandia 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.230
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.219
Princeton 848
Chandler 538
Wilmington 494
Jacksonville 427
Singapore 355
Dublin 300
Izmir 265
Woodbridge 216
Ashburn 201
Houston 190
Salerno 186
Dong Ket 162
Moscow 152
Andover 127
Hong Kong 124
Pellezzano 121
Nanjing 115
Beijing 114
Naples 96
Boardman 69
Norwalk 69
Fairfield 62
Düsseldorf 44
Dallas 43
Shenyang 43
Munich 39
The Dalles 37
Hebei 36
Tallinn 36
Nanchang 34
Nuremberg 34
Pune 34
Los Angeles 33
Dearborn 29
Changsha 28
Mestre 27
São Paulo 27
West Jordan 27
Jiaxing 26
Columbus 23
San Diego 23
Redwood City 22
Seattle 21
Turku 18
Belo Horizonte 17
Brasília 17
Council Bluffs 16
Washington 16
Cambridge 15
Rome 15
Sydney 15
Lecce 14
Tianjin 14
Amsterdam 13
Auckland 13
Guangzhou 13
New York 13
Rio de Janeiro 13
Falls Church 12
London 12
San Francisco 11
Brno 10
Fort Worth 10
Orange 10
Montreal 9
Toronto 9
Curitiba 8
Jinan 8
Johannesburg 8
Milan 8
Lappeenranta 7
Melbourne 7
Shanghai 7
Stockholm 7
Tashkent 7
Vienna 7
Warsaw 7
Assago 6
Carapicuíba 6
Dormagen 6
Santa Clara 6
Tokyo 6
Atlanta 5
Baghdad 5
Boston 5
Brussels 5
Casoria 5
Chicago 5
Fortaleza 5
Genoa 5
Goiânia 5
Guarulhos 5
Nairobi 5
Perugia 5
Porto Alegre 5
Santa Maria A Vico 5
Uberlândia 5
Anápolis 4
Asunción 4
Totale 7.615
Salva come PNG Salva come JPEG
Nome #
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 157
Apathy in untreated, de novo patients with Parkinson’s disease: validation study of Apathy Evaluation Scale 132
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 128
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 128
Are granular osmiophilic material deposits an epiphenomenon in CADASIL? 115
Toward the premotor diagnosis of Parkinson's disease: Suggestions from a modelling study 115
Increased bilirubin levels in de novo Parkinson's disease 114
Link between non-motor symptoms and cognitive dysfunctions in de novo, drug-naive PD patients. 111
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 109
Regional gray matter atrophy in patients with Parkinson disease and freezing of gait 107
A two-year follow-up study of executive dysfunctions in parkinsonian patients with freezing of gait at on-state. 104
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson’s disease 99
Gender and non motor fluctuations in Parkinson's disease: A prospective study 97
A Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease 97
Malabsorption is uncommon in restless legs syndrome. 95
Serum uric acid is associated with apathy in early, drug-naïve Parkinson’s disease 95
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients. 94
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 94
Mild Cognitive Impairment in newly diagnosed Parkinson's disease: A longitudinal prospective study 93
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson’s disease 92
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study 92
On the relationship between side of onset and cognition in Parkinson disease 90
Apathy evaluation scale-informant version in progressive supranuclear palsy: Psychometric properties and clinical correlates 88
Quitting smoking: An early non-motor feature of Parkinson's disease? 86
Early MRI findings in acquired hepatocerebral degeneration. 86
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy. 85
Abnormal eating behaviors in progressive supranuclear palsy. 84
White matter changes and the development of motor phenotypes in de novo Parkinson's Disease 84
Regional Gray Matter Atrophy in Patients with Parkinson Disease and Freezing of Gait. 84
Relationship between apathy and cognitive dysfunctions in de novo untreated Parkinson's disease: a prospective longitudinal study. 83
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 83
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients. 83
Segmental progression of cardinal motor symptoms in Parkinson's disease: A pilot study suggesting a practical approach to rate disease course in the early stages. 82
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 81
Association of MRI Measures With Disease Severity and Progression in Progressive Supranuclear Palsy 81
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 80
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease. 79
Presence and progression of non-motor symptoms in relation to uric acid inde novoParkinson's disease 79
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease 79
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: A 4-year longitudinal study 78
Uric acid relates to dopamine transporter availability in Parkinson's disease. 76
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease. 76
A novel therapeutic approach for synucleinopathies 76
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 73
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients 72
Patients with Parkinson?s disease and scans with (predominant) ipsilateral dopaminergic deficit 72
Non-motor correlates of smoking habits in de novo Parkinson's disease 72
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 71
Comment on Numao et al.: Clinical correlates of serum insulin-like growth factor-1 in patients with Parkinson's disease, multiple system atrophy and progressive supranuclear palsy 70
Gender differences in non-motor symptoms in early Parkinson's disease: A 2-years follow-up study on previously untreated patients. 69
Non-invasive brain stimulation for dystonia: therapeutic implications 69
Do Subjective Memory Complaints Herald the Onset of Mild Cognitive Impairment in Parkinson Disease? 68
Mutation in theSYNJ1Gene Associated with Autosomal Recessive, Early-Onset Parkinsonism 67
Comparing PIGD and Akinetic-Rigid subtyping of Parkinson Disease and their stability over time 65
The "eye of the tiger" sign in pure akinesia with gait freezing. 64
Non-motor symptoms in early Parkinson's disease: a 2-year follow-up study on previously untreated patients. 64
Impulse control disorders induced by rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 cases 63
Comment on Di Giuda et al.: Dopaminergic dysfunction and psychiatric symptoms in movement disorders: a (123)I-FP-CIT SPECT study. 62
Affective and cognitive theory of mind in patients with cervical dystonia with and without tremor 62
Mild cognitive impairment in drug-naive patients with PD is associated withcerebral hypometabolism 61
Progressive Parkinsonism, Balance Difficulties, and Supranuclear Gaze Palsy 61
Hemi-restless legs syndrome induced by clebopride 61
Nutritional habits, risk, and progression of Parkinson disease 61
Clinical use of SAND battery to evaluate language in patients with Progressive Supranuclear Palsy 60
Teaching NeuroImages: Pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 59
Restless legs syndrome is a common feature of adult celiac disease 59
MDS PSP criteria in real-life clinical setting: Motor and cognitive characterization of subtypes 58
Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials 58
ADCY5 mutations are another cause of benign hereditary chorea 57
Olfactory impairment and pathology in neurodegenerative disorders with brain iron accumulation 56
Midbrain MRI assessments in progressive supranuclear palsy subtypes 56
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 54
Gait Analysis in Progressive Supranuclear Palsy Phenotypes. 54
Olfaction in Homozygous and Heterozygous SYNJ1 Arg258Gln Mutation Carriers 53
Abnormal nociceptive processing occurs centrally and not peripherally in pain-free Parkinson disease patients: A study with laser-evoked potentials 53
Bipolar Disorder and Parkinson’s Disease: A 123I-Ioflupane Dopamine Transporter SPECT Study 53
Neurophysiological correlates of abnormal somatosensory temporal discrimination in dystonia 52
The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review 51
Effects of gender on cognitive and behavioral manifestations in multiple system atrophy 51
Retinal thinning in progressive supranuclear palsy: differences with healthy controls and correlation with clinical variables 51
Comparative cognitive and neuropsychiatric profiles between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy 50
The role of disease duration and severity on novel clinical subtypes of Parkinson disease 49
When shaking during standing points to hereditary spastic paraplegias 48
[¹²³I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis. 48
A Pilot Study of Botulinum Toxin for Jerky, Position-Specific, Upper Limb Action Tremor 48
“Atypical” atypical parkinsonism: Critical appraisal of a cohort 48
Seizures and movement disorders: Phenomenology, diagnostic challenges and therapeutic approaches 48
Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease 48
Cortical and spinal excitability in patients with multiple sclerosis and spasticity after oromucosal cannabinoid spray 47
Psychometric properties of the Beck Depression Inventory-II in progressive supranuclear palsy 47
Mental rotation and working memory in musicians’ dystonia 46
The PRIAMO study: urinary dysfunction as a marker of disease progression in early Parkinson's disease 44
Functional gait disorders: Demographic and clinical correlations 44
What do patients with scans without evidence of dopaminergic deficit (SWEDD) have? New evidence and continuing controversies 43
Parkinsonism following neuroleptic exposure: a double-hit hypothesis? 43
Motor, cognitive and behavioral differences in MDS PSP phenotypes 43
Why do people google movement disorders? An infodemiological study of information seeking behaviors 42
A (single case) rehabilitation program based on cueing for freezing of speech 42
Energy expenditure, body composition and dietary habits in progressive supranuclear palsy 42
The Distinguishing Motor Features of Cataplexy: A Study from Video Recorded Attacks 41
Totale 7.244
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021679 2 45 57 11 77 60 70 6 58 2 81 210
2021/20221.275 5 1 5 9 24 8 17 37 146 164 216 643
2022/20231.556 242 102 73 141 171 371 18 129 202 8 66 33
2023/20241.005 45 132 57 61 46 120 37 77 49 66 55 260
2024/20252.997 84 40 50 121 116 342 372 261 452 422 371 366
2025/202682 82 0 0 0 0 0 0 0 0 0 0 0
Totale 11.812